Headlines Sight Sciences Completes $30M Financing Round It’s working on technology for glaucoma and dry eye disease. Published 10 months ago on March 27, 2020 By INVISION Staff Share Tweet MENLO PARK, CA — Sight Sciences Inc., a medical device company working on technology for treatment of glaucoma and dry eye disease, announced the closing of an over $30 million financing round. Proceeds will be used for continued clinical and operational development and to support commercial expansion for Sight Sciences’ OMNI and TearCare products, according to a press release. The Series E preferred stock round was led by D1 Capital Partners. INVISION Podcast What’s Really Up with Vision Expo in 2021? INVISION Podcast Podcast: Talking with the Finest, Hippest of Them All About Why There are No Ball Point Pens in Her Shop INVISION Podcast Licensed or Not, Member or Not, the Opticians Association of America is Here for You [Podcast] “Sight Sciences has introduced two technologies that have fundamentally improved how physicians can treat two of the most prevalent eye diseases. In minimally invasive glaucoma surgery the safety, efficacy and versatility of the OMNI device is unmatched,” said James Rogers, analyst at D1 Capital Partners. “Additionally, we feel the early success with the commercialization of TearCare suggests this innovative and effective solution has addressed the shortfalls of previous dry eye treatments and modalities for this common ailment.” Glaucoma affects 80 million people globally and is the leading cause of irreversible blindness in the aging world population. Dry eye disease afflicts 350 million people globally and is the leading cause of visits to an eyecare provider. “We are thrilled to be closing a significant growth investment round with D1,” said Jesse Selnick, CFO of Sight Sciences. “D1 is truly a perfect fit for our company at this stage, combining the scale, market reach, investment talent and operational acumen of a large, premier asset manager with the flexible mandate and long-term investment horizon of a family office.” Advertisement Founded by Daniel Sundheim in 2018, D1 currently has $10 billion of capital under management and invests in the global internet, technology, telecom, media, consumer, healthcare, industrial and real estate sectors. Sight Sciences represents the third late-stage private healthcare investment made by D1 in the last 18 months. “We are extremely excited to partner with D1 over the long term,” said Paul Badawi, founder and CEO of Sight Sciences. “This investment further validates the substantial progress we have made in our mission to transform the treatment of the world’s most prevalent eye diseases. Through further clinical trials and continued scale-up of our commercial infrastructure, we are looking forward to accelerating the market development of both standalone MIGS with OMNI and procedure-based dry eye therapy with TearCare.” Related Topics:Latest News TopSight Sciences click to Comment(Comment) Up Next COVID-19 Resource Center for ECPs Don't Miss COVID-19 Relief for Optometrists: AOA Announces Coronavirus Package for ECPs INVISION Staff Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at [email protected]. Advertisement SPONSORED VIDEO SPONSORED BY ESSILOR Ray-Ban® Authentic Introducing the perfect match of Ray-Ban's legendary style and Essilor's Expertise in sight. Click here for more information. You may like Pacific Vision Surgery Center Opens Doors to Bay Area Community 2020 Holiday Sales Grew 8% Despite Pandemic, NRF Reports Ray-Ban® Authentic Promoted Headlines Ray-Ban® Authentic Essilor Get More with Essilor Essilor 360° SUPPORT. 365 DAYS A YEAR. Essilor Advertisement Latest Trending Videos Press Releases19 hours ago Pacific Vision Surgery Center Opens Doors to Bay Area Community Press Releases21 hours ago 2020 Holiday Sales Grew 8% Despite Pandemic, NRF Reports Sponsored Content1 day ago Ray-Ban® Authentic Headlines3 days ago Eyecare Center Offers Free Laser Surgery for NFL Referee After Controversial Call Press Releases3 days ago ReFocus Eye Health Partners with Eye Center of Southern Connecticut America's Finest 2019 Entries2 weeks ago America’s Finest: Before You Start America's Finest 2019 Entries3 weeks ago America’s Finest: Get Your Contest Entry in Great Shape America's Finest 2019 Entries2 weeks ago America’s Finest: Basic Info and Stats America's Finest 2019 Entries2 weeks ago America’s Finest: You Gotta Stand Out from the Crowd America's Finest 2019 Entries2 weeks ago America’s Finest: Photos Really Are Worth at Least a Thousand Words Sponsored Content1 day ago Ray-Ban® Authentic Sponsored Content7 days ago Get More with Essilor Sponsored Content1 month ago Perform Refraction from Anywhere with RDx Headlines3 months ago Video: Florida Man Invents Robot to Place Contact Lenses Headlines3 months ago Video: Some Retailers Board Up Due to Election Unrest Fears Advertisement Advertisement SubscribeBULLETINS Get the most important news and business ideas for eyecare professionals every weekday from INVISION. Facebook Most Popular Photo Gallery1 week ago 12 Images That Show Why Zionsville Eyecare in Zionsville, IN, Was Named One of America’s Finest Optical Retailers Press Releases1 week ago EnChroma Names Vision Industry Veteran Erik Ritchie as CEO Headlines3 days ago Eyecare Center Offers Free Laser Surgery for NFL Referee After Controversial Call Headlines6 days ago Massachusetts ODs Win Right to Treat Glaucoma Sponsored Content7 days ago Get More with Essilor Columns6 days ago 2021 Is a New Year… Let’s Make Your Marketing New, Too! Press Releases1 week ago Eco Helps Trees for the Future Reach 200M Trees Sponsored Content1 week ago 360° SUPPORT. 365 DAYS A YEAR.